NCT07554339
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07554339
Title A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NHO Revive Research Institute LLC ( Site 0118) RECRUITING Lincoln Nebraska 68506 United States Details
Keimyung University Dongsan Hospital ( Site 2503) RECRUITING Daegu Taegu-Kwangyokshi 42601 South Korea Details
National Cheng Kung University Hospital ( Site 2601) RECRUITING Tainan 704 Taiwan Details
Municipal non-profit enterprise'Odesa Regional Clinical Hospital'of Odesa Regional Council ( Site 2011) RECRUITING Odesa Odesa Oblast 65025 Ukraine Details
Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council" ( Site 2004) RECRUITING Vinnytsia Vinnytsia Oblast 21029 Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field